Literature DB >> 16698313

Docosahexaenoic acid enrichment can reduce L929 cell necrosis induced by tumor necrosis factor.

Etsu Kishida1, Michiko Tajiri, Yasuo Masuzawa.   

Abstract

We previously reported that docosahexaenoic acid (DHA) attenuated tumor necrosis factor (TNF)-induced apoptosis in human monocytic U937 cells (J. Nutr. 130: 1095-1101, 2000). In the present study, we examined the effects of DHA and other polyunsaturated fatty acids (PUFA) on TNF-induced necrosis, another mode of cell death, using L929 murine fibrosarcoma cells. After preincubation with PUFA conjugated with BSA for 24 h, cells were treated with TNF or TNF+actinomycin D (Act D). Preincubation of cells with DHA enriched this polyunsaturated acid in the phospholipids and attenuated cell death induced by either TNF or TNF+Act D. When cells were treated with TNF alone, DNA laddering was not detected, and cells were coincidently stained with both annexin V-FITC and propidium iodide, indicating that the death mode was necrotic. TNF+Act D predominantly induced necrosis, although concurrent apoptotic cell death was also observed in this case. Preincubation with oleic acid, linoleic acid or 20:3(n-3) did not affect TNF-induced necrosis. Conversely, supplementation with n-3 docosapentaenoic acid (DPAn-3) or eicosapentaenoic acid (EPA) reduced necrotic cell death, but to a lesser extent in comparison with DHA. Unlike the case of U937 cell apoptosis, arachidonic acid (AA) significantly attenuated L929 cell necrosis, and 20:3(n-6) or 22:4(n-6) showed similar or less activity, respectively. Statistical evaluation indicated that the order of effective PUFA activity was DHA>DPAn-3> or =EPA>AA approximately 20:3(n-6)> or =22:4(n-6). One step desaturation, C2 elongation or C2 cleavage within the n-6 or n-3 fatty acid group was probably very active in L929 cells, because AA, synthesized from 20:3(n-6) or 22:4(n-6), and C22 fatty acids, synthesized from AA or EPA, were preferentially retained in cellular phospholipids. These observations suggested that attenuation of TNF-induced necrosis by the supplementation of various C20 or C22 polyunsaturated fatty acids is mainly attributable to the enrichment of three kinds of polyunsaturated fatty acids, i.e., DHA, DPAn-3 or AA, in phospholipids. Among these fatty acids, DHA was the most effective in the reduction of L929 necrosis as observed in the case of U937 apoptosis. This suggests that DHA-enriched membranes can protect cell against TNF irrespective of death modes and that membranous DHA may abrogate the death signaling common to necrosis and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698313     DOI: 10.1016/j.bbalip.2006.03.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  A short-term n-3 DPA supplementation study in humans.

Authors:  Eliza Miller; Gunveen Kaur; Amy Larsen; Su Peng Loh; Kaisa Linderborg; Harrison S Weisinger; Giovanni M Turchini; David Cameron-Smith; Andrew J Sinclair
Journal:  Eur J Nutr       Date:  2012-06-23       Impact factor: 5.614

2.  Cytoprotective effect of γ-tocopherol against tumor necrosis factor α induced cell dysfunction in L929 cells.

Authors:  Gabor Oláh; Katalin Módis; Domokos Gero; Kunihiro Suzuki; Douglas Dewitt; Daniel L Traber; Csaba Szabó
Journal:  Int J Mol Med       Date:  2011-08-05       Impact factor: 4.101

3.  Docosahexanoic acid antagonizes TNF-α-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features.

Authors:  Fabio J Pacheco; Frankis G Almaguel; Whitney Evans; Leslimar Rios-Colon; Valery Filippov; Lai S Leoh; Elizabeth Rook-Arena; Melanie Mediavilla-Varela; Marino De Leon; Carlos A Casiano
Journal:  Inflamm Res       Date:  2014-08-06       Impact factor: 4.575

4.  Binge ethanol-induced neurodegeneration in rat organotypic brain slice cultures: effects of PLA2 inhibitor mepacrine and docosahexaenoic acid (DHA).

Authors:  James Brown; Nicholas Achille; Edward J Neafsey; Michael A Collins
Journal:  Neurochem Res       Date:  2008-07-01       Impact factor: 3.996

5.  The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: A meta-analysis.

Authors:  Michael E Chua; Maria Christina D Sio; Mishell C Sorongon; Marcelino L Morales
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

6.  Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer.

Authors:  Mishell Kris Sorongon-Legaspi; Michael Chua; Maria Christina Sio; Marcelino Morales
Journal:  Prostate Cancer       Date:  2013-03-25

Review 7.  A review of the biologic and pharmacologic role of docosapentaenoic acid n-3.

Authors:  Puya G Yazdi
Journal:  F1000Res       Date:  2013-11-25

8.  The effects of n-3 fatty acids on inflammatory cytokines in osteoporotic spinal cord injured patients: A randomized clinical trial.

Authors:  Hadis Sabour; Bagher Larijani; Mohammad Reza Vafa; Mohammad Reza Hadian; Ramin Heshmat; Hamidreza Aghaei Meybodi; Hasan Emami Razavi; Abbas Norouzia Javidan; Farzad Shidfar
Journal:  J Res Med Sci       Date:  2012-04       Impact factor: 1.852

9.  The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumour necrosis factor (TNF)-alpha during murine skeletal muscle cell differentiation.

Authors:  Peter Magee; Stephen Pearson; Jeremy Allen
Journal:  Lipids Health Dis       Date:  2008-07-18       Impact factor: 3.876

10.  Effect of n-3 fatty acids on the expression of inflammatory genes in THP-1 macrophages.

Authors:  Bénédicte Allam-Ndoul; Frédéric Guénard; Olivier Barbier; Marie-Claude Vohl
Journal:  Lipids Health Dis       Date:  2016-04-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.